Research ArticleBasic Science Investigation
Imaging CXCR4 Expression in Human Cancer Xenografts: Evaluation of Monocyclam 64Cu-AMD3465
Ravindra A. De Silva, Kevin Peyre, Mrudula Pullambhatla, James J. Fox, Martin G. Pomper and Sridhar Nimmagadda
Journal of Nuclear Medicine June 2011, 52 (6) 986-993; DOI: https://doi.org/10.2967/jnumed.110.085613
Ravindra A. De Silva
Kevin Peyre
Mrudula Pullambhatla
James J. Fox
Martin G. Pomper
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 52, Issue 6
June 1, 2011
Imaging CXCR4 Expression in Human Cancer Xenografts: Evaluation of Monocyclam 64Cu-AMD3465
Ravindra A. De Silva, Kevin Peyre, Mrudula Pullambhatla, James J. Fox, Martin G. Pomper, Sridhar Nimmagadda
Journal of Nuclear Medicine Jun 2011, 52 (6) 986-993; DOI: 10.2967/jnumed.110.085613
Jump to section
Related Articles
Cited By...
- Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET
- 64Cu PET Imaging of the CXCR4 Chemokine Receptor Using a Cross-Bridged Cyclam Bis-Tetraazamacrocyclic Antagonist
- Modulators of CXCR4 and CXCR7/ACKR3 Function
- Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia
- Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
- In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
- Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics
- CXCR4-Based Imaging Agents